• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sage Therapeutic Com (NQ: SAGE )

    10.78 +0.16 (+1.51%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 656,449
    Open 10.57
    Bid (Size) 10.20 (1)
    Ask (Size) 12.00 (1)
    Prev. Close 10.62
    Today's Range 10.30 - 10.99
    52wk Range 9.760 - 49.74
    Shares Outstanding 59,762,106
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    19 Analysts Have This To Say About Sage Therapeutics
    Via Benzinga
    Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    -52.05%
    -52.05%
    1 Month
    +0.09%
    +0.09%
    3 Month
    -35.06%
    -35.06%
    6 Month
    -57.05%
    -57.05%
    1 Year
    -76.44%
    -76.44%

    More News

    Read More
    Sage Therapeutics Reports Phase 2 Huntington's Data
    Via Benzinga
    Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease
    From Sage Therapeutics
    Via Business Wire
    Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
    From Sage Therapeutics, Inc.
    Via Business Wire
    Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
    Via Benzinga
    In-Depth Examination Of 9 Analyst Recommendations For Sage Therapeutics
    Via Benzinga
    Wall Street's Top 10 Stock Calls This Week - Sunday, June 2
    Via Talk Markets
    Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
    Via Benzinga
    Sage Therapeutics to Participate in Upcoming May Investor Conferences
    From Sage Therapeutics
    Via Business Wire
    SAGE Stock Earnings: Sage Therapeutics Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
    From Sage Therapeutics, Inc.
    Via Business Wire
    Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Sage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    J B Hunt Transport Reports Downbeat Earnings, Joins ASML And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
    From Sage Therapeutics, Inc.
    Via Business Wire
    Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
    From Sage Therapeutics, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.